The challenge: Identifying and monitoring current and potential competitors and assessing their risk appetite.
A major pharmaceutical company approached LucidQuest and asked for our support to monitor current and upcoming generic competitors, their ability to meet their target launch timelines, and the likelihood of launching at-risk.
The action: Primary and secondary research to identify potential competitors, uncover their plans and select which to monitor.
LucidQuest conducted extensive primary and secondary research and identified all potential generic manufacturers and their plans to enter a crowded field. Working with the client, LucidQuest then monitored a selection of key potential entrants for their manufacturing capabilities and “appetite” for at-risk launches.
The result: Focusing on what matters.The client gained a realistic perception of competition and settled specific court actions.
LucidQuest was able to strongly allay the client’s concerns over an unlikely at-risk launch. At the same time, we further identified additional potential generic competitors that should be sporadically monitored but did not pose a severe threat. This intelligence entered into the client’s decision process to settle specific court actions with some potential competitors.
#Pharma #Generics #pharmamanufacturing #pharmalaunch #MarketIntelligence #casestudy #ourwork